Plunkett Research Online: Hypera SA

HYPERA SA (HYPMY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Hypera SA operates as Hypera Pharma and is a leading pharmaceutical company in Brazil. Hypera Pharma’s prescription products business offers a portfolio of medicines and dermocosmetics. Medicines include both prescription and over-the-counter offerings, with prescription brands including Amplium, .....



Hypera SA
Ticker: HYPMY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 55 1136274242
Fax: 55 1136274371
Address: Avenida Magalhaes de Castro, 4800
24 andar-Edificio Continental Tower
Bairro Cidade Jardim
Sao Paulo, SP CEP 05676-120 Brazil

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Personal Care Products
Pharmaceuticals
Contacts Description

Breno Toledo Pires de Oliveira CEO
Hypera SA operates as Hypera Pharma and is a leading pharmaceutical company in Brazil. Hypera Pharma’s prescription products business offers a portfolio of medicines and dermocosmetics. Medicines include both prescription and over-the-counter offerings, with prescription brands including Amplium, .....See More See More

Auditor: PricewaterhouseCoopers Auditores Independentes
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Hypera Pharma
Amplium
Eucil
Lipanon
Agecare
Blancy
Adocyl
Zero-Cal
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: